Bardy Diagnostics™ Selected as a Winner of the Children’s National Pediatric Medical Device Innovation Competition

SEATTLE, Sept. 26, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced it was selected as one of six winners of the […]

Huami Announces Launch of New Amazfit Health Band 1S and Introduces Groundbreaking Smart Wearable AI Chip, Huangshan-1

BEIJING, Sept. 18, 2018 /PRNewswire/ — Huami Corporation (“Huami” or the “Company”) (NYSE: HMI), a biometric and activity data-driven company with significant expertise in smart wearable technology, today announced the launch of the new generation health band, Amazfit Health Band 1S, which delivers new features and benefits powered by AI technologies and brings advanced […]

AtaCor Medical Raises $8.8M to Develop Substernal Cardiac Pacing System

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. (www.atacor.com) announced today that it has completed a $8.8M Series A financing. Co-led by Boston-based Broadview Ventures and Israel-based aMoon Ventures, the financing also includes participation from a corporate partner. The investment will support the continued development of AtaCor’s revolutionary extravascular substernal cardiac pacing […]

Apple Watch Series 4: Beautifully Redesigned With Breakthrough Communication, Fitness and Health Capabilities

CUPERTINO, Calif.–(BUSINESS WIRE)–Apple® today introduced Apple Watch® Series 4, redesigned and re-engineered to help users stay connected, be more active and manage their health in powerful new ways. While retaining the original iconic design, the fourth-generation Apple Watch has been refined, combining new hardware and software enhancements into a genuinely singular, […]


DUBLIN – September 11, 2018 – Today, Medtronic issued the following statement confirming it has received FDA warning letters (CMS #560736 and #562437) related to its Cardiac Rhythm and Heart Failure facilities located in Mounds View, Minn., and in Juncos, Puerto Rico. The warning letters reflect earlier FDA inspection reports from […]

With Latest FDA 510(k), physIQ Achieves Another Clearance as a Pioneer in AI Analytics

CHICAGO–(BUSINESS WIRE)–PhysIQ, a leader in applying AI analytics to biosensor data, today announced it has received FDA 510(k) clearance for its Atrial Fibrillation (AFib) detection analytics engine. The clearance extends physIQ’s portfolio of FDA 510(k) cleared analytics designed to generate clinical insight from wearable biosensors and further establishes physIQ as a […]

FDA Designates AliveCor’s Bloodless Hyperkalemia Test a “Breakthrough Device”

MOUNTAIN VIEW, Calif., Sept. 10, 201 /PRNewswire/ — AliveCor, recently recognized as the Most Innovative Company in Artificial Intelligence, today announced that the U.S. Food and Drug Administration has given the company’s KardiaK Software Platform the rarely granted designation of “Breakthrough Device.” This designation means that the FDA will consider the technology […]

InfoBionic Secures $50 Million in Financing to Support Continued Growth of the MoMe® Kardia System for Cardiac Arrhythmia Detection

BOSTON–(BUSINESS WIRE)–InfoBionic, a digital health company focused on patient-monitoring solutions for chronic disease management, today announced the completion of a $50 million financing to support continued commercial expansion of its MoMe® Kardia system for remote, wireless outpatient monitoring and diagnosis of cardiac arrhythmias. The financing round includes participation by Eagle Investments; Excel Venture Management; Safeguard Scientifics; Zaffre […]

Cardiac Insight’s Wearable ECG Sensor, Cardea SOLO™, Continues to Attract Premier Cardiology Groups Across the U.S.; Announces Baltimore Heart Associates and Regional Cardiac Arrhythmia as Customers

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable biosensors and diagnostic software systems featuring proprietary automated data analysis algorithms, announced today that its wearable ECG Sensor, Cardea SOLO, continues to attract high-volume cardiology group practices across the U.S. The company unveiled Baltimore Heart Associates of Maryland (www.baltimoreheart.com) […]

Leviticus Cardio Announces Successful Completion of Third Chronic Animal Study

PETAH TIKVA, Israel, Sept. 6 2018 /PRNewswire/ — Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump. The […]